Generic drugs in the US are too cheap to be sustainable, experts say
theguardian.com
theguardian.com
https://www.csrxp.org/icymi-new-study-finds-big-pharma-spent...
Even given dictatorial power over the FDA I'm still not sure exactly what I would do to untangle the swirl of incentive problems here.
Use statistical modeling to determine the likely need for various generic drugs over time, and hire generic producers to make enough to accommodate that need, leveraging feedback loops to adjust the quantities and types of what’s ordered?
Why is it that people think a large corporation is perfectly capable of “enterprise resource planning” but when it comes to a government agency suddenly it’s “central planning” and therefore impossible?